HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,432: | Line 1,432: | ||
|Hairy Cell Leukemia | |Hairy Cell Leukemia | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| || || || || ||SG|| || | |[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| || || || || ||SG|| || | ||
| | |Splenic Marginal Zone Lymphoma | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| || | |[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| || | ||
| | |Splenic Diffuse Red Pulp Small B-cell Lymphoma | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 1,460: | Line 1,460: | ||
| | | | ||
| | | | ||
| | |Hairy Cell Leukemia Variant | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 1,476: | Line 1,476: | ||
| | | | ||
| | | | ||
| | |Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia | ||
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | |Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | ||
| | |Complete | ||
| | |4/12/2023 by FQR | ||
| | | | ||
|- | |- | ||
| Line 1,492: | Line 1,492: | ||
| | | | ||
| | | | ||
| | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | ||
| | |Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG* | ||
| | |||
| | Department of Pathology and Laboratory Medicine and *Pediatrics, School of Medicine, University of California Irvine (UCI) | ||
|Complete | |||
|4/12/23 by FQR | |||
| | | | ||
|- | |- | ||
| Line 1,508: | Line 1,510: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]] | |[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]] | ||
| Line 1,524: | Line 1,526: | ||
| | | | ||
| | | | ||
| | |Nodal Marginal Zone Lymphoma | ||
|Andrew Ly, DO and Shivani Golem, PhD, FACMG | |Andrew Ly, DO and Shivani Golem, PhD, FACMG | ||
| | |Complete | ||
| | |5/28/2021 | ||
| | | | ||
|- | |- | ||
| Line 1,540: | Line 1,542: | ||
| | | | ||
| | | | ||
| | |Paediatric Nodal Marginal Zone Lymphoma | ||
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | |* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | ||
| | |Complete | ||
| | |11/11/2020 | ||
| | | | ||
|- | |- | ||
| Line 1,622: | Line 1,624: | ||
| | | | ||
|Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | |Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | ||
| | |Complete | ||
| | |09/10/2022 | ||
| | | | ||
|- | |- | ||